Cargando…

Identification of clinical, epidemiological and laboratory risk factors for leprosy reactions during and after multidrug therapy

This cross-sectional retrospective study evaluated 440 leprosy patients; 57% (251/440) had leprosy reactions during and/or after multidrug therapy, 80.5% (202/251) of whom presented with multibacillary leprosy. At diagnosis, positive bacterial index (BI) [odds ratio (OR) = 6.39; 95% confidence inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antunes, Douglas Eulálio, Araujo, Sergio, Ferreira, Gabriela Porto, da Cunha, Ana Carolina Sousa Rodrigues, da Costa, Adeilson Vieira, Gonçalves, Maria Aparecida, Goulart, Isabela Maria Bernardes
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Oswaldo Cruz, Ministério da Saúde 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970646/ https://www.ncbi.nlm.nih.gov/pubmed/24271045 http://dx.doi.org/10.1590/0074-0276130222

Ejemplares similares

Will cases of leprosy reaction increase with COVID-19 infection?
por: Antunes, Douglas Eulálio, et al.
Publicado: (2020)

Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study
por: Antunes, Douglas Eulálio, et al.
Publicado: (2022)

Evaluation of the cutaneous sensation of the face in patients with different clinical forms of leprosy
por: de Oliveira, Marlice Fernandes, et al.
Publicado: (2019)

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy
por: Goulart, Isabela Maria Bernardes, et al.
Publicado: (2022)

Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum
por: Antunes, Douglas Eulálio, et al.
Publicado: (2019)

Revisiting primary neural leprosy: Clinical, serological, molecular, and neurophysiological aspects
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2017)

Molecular, immunological and neurophysiological evaluations for early diagnosis of neural impairment in seropositive leprosy household contacts
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2018)

Assessment of neuropathic pain in leprosy patients with relapse or treatment failure by infrared thermography: A cross-sectional study
por: Tiago, Liliane Marques de Pinho, et al.
Publicado: (2021)

High-resolution ultrasonography for early diagnosis of neural impairment in seropositive leprosy household contacts
por: Luppi, Andrea De Martino, et al.
Publicado: (2023)

Early diagnosis of neural impairment in seropositive leprosy household contacts: The experience of a reference center in Brazil
por: dos Santos, Diogo Fernandes, et al.
Publicado: (2023)

Anti-Lipoarabinomannan-Specific Salivary IgA as Prognostic Marker for Leprosy Reactions in Patients and Cellular Immunity in Contacts
por: Nahas, André Alan, et al.
Publicado: (2018)

Antigen-specific assessment of the immunological status of various groups in a leprosy endemic region
por: Fabri, Angélica da Conceição Oliveira Coelho, et al.
Publicado: (2015)

Progressive neuropathy in patients with lepromatous leprosy after multidrug therapy
por: Penna, Patricia Sola, et al.
Publicado: (2023)

Leprosy: current situation, clinical and laboratory aspects, treatment history and perspective of the uniform multidrug therapy for all patients
por: Cruz, Rossilene Conceição da Silva, et al.
Publicado: (2017)

Fever of Unknown Origin, Wasting Syndrome and Bone Marrow Involvement: A Leprosy Case Report
por: Santana, Marcela Araujo de Oliveira, et al.
Publicado: (2022)

HSP60 mimetic peptides from Mycobacterium leprae as new antigens for immunodiagnosis of Leprosy
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2023)

Factors associated to quality of life in patients with leprosy
por: Pinto, Graziele Ferreira, et al.
Publicado: (2021)

Progression of leprosy disability after discharge: is multidrug therapy enough?
por: Sales, Anna Maria, et al.
Publicado: (2013)

Serum levels of inflammatory cytokines in leprosy patients
por: de Paula, Lúcia, et al.
Publicado: (2010)

Gene expression patterns associated with multidrug therapy in multibacillary leprosy
por: Ferreira, Helen, et al.
Publicado: (2022)

Fibrosis: a distinguishing feature in the pathology of neural leprosy
por: Antunes, Sérgio Luiz Gomes, et al.
Publicado: (2019)

Biotechnological and Immunological Platforms Based on PGL-I Carbohydrate-Like Peptide of Mycobacterium leprae for Antibodies Detection Among Leprosy Clinical Forms
por: Lima, Mayara Ingrid Sousa, et al.
Publicado: (2020)

Risk factors for physical disability upon release from multidrug therapy in new cases of leprosy at a referral center in Brazil
por: Assis, Bárbara Proença Nardi, et al.
Publicado: (2019)

Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
por: Cruz, Rossilene Conceição da Silva, et al.
Publicado: (2018)

Leprosy: a review of laboratory and therapeutic aspects - Part 2()
por: Lastória, Joel Carlos, et al.
Publicado: (2014)

Meaning of leprosy for people who have experienced treatment during the sulfonic and multidrug therapy periods
por: Santos, Karen da Silva, et al.
Publicado: (2015)

Protein profile of leprosy patients with plantar ulcers from the Eastern Amazon region
por: de Oliveira, Marineia Porto, et al.
Publicado: (2017)

Evaluation of the social, clinical and laboratorial profile of patients diagnosed with leprosy in a reference center in São Paulo()
por: Porto, Ana Carolina Souza, et al.
Publicado: (2015)

Seroepidemiologic survey of the household contacts of leprosy patients
por: Barbosa, Angela Marques, et al.
Publicado: (2022)

Primary Multidrug-Resistant Leprosy, United States
por: Williams, Diana Lynn, et al.
Publicado: (2013)

Multidrug-resistant tuberculosis and leprosy: An unsolved mystery
por: Al-Mendalawi, Mahmood Dhahir
Publicado: (2017)

Multidrug-resistant tuberculosis and leprosy: An unsolved mystery
por: Gupta, Robin, et al.
Publicado: (2017)

Can baseline ML Flow test results predict leprosy reactions? An investigation in a cohort of patients enrolled in the uniform multidrug therapy clinical trial for leprosy patients in Brazil
por: Hungria, Emerith Mayra, et al.
Publicado: (2016)

Evidence of hidden leprosy in a supposedly low endemic area of Brazil
por: Bernardes, Fred, et al.
Publicado: (2017)

Uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): Results of an open label, randomized and controlled clinical trial, among multibacillary patients
por: Penna, Gerson Oliveira, et al.
Publicado: (2017)

PCR-Based Techniques for Leprosy Diagnosis: From the Laboratory to the Clinic
por: Martinez, Alejandra Nóbrega, et al.
Publicado: (2014)

Adverse effects of alternative therapy (minocycline, ofloxacin, and clofazimine) in multibacillary leprosy patients in a recognized health care unit in Manaus, Amazonas, Brazil
por: Maia, Marina Valente, et al.
Publicado: (2013)

Crusted scabies in a patient with lepromatous leprosy
por: Pedra e Cal, Alexandra Peres Paim, et al.
Publicado: (2016)

Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis
por: Montezuma, Thais, et al.
Publicado: (2023)

Uniform multidrug therapy for leprosy – time for a rethink?
por: Saunderson, Paul R.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_qobela87mdmmb52c9j9aj6775d